Kensey Nash Corporation (Nasdaq: KNSY) announced that it has received CE Mark Approval for its ThromCat Thrombectomy Catheter System, which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE